Work

O1‐12‐06: Phase 1 Multiple Ascending Dose (mad) Study of Phosphodiesterase‐9 Inhibitor E2027: Confirmation of Target Engagement and Selection of Phase 2 Dose in Dementia With Lewy Bodies